Retatrutide for Obesity, Ebola Testing in Ontario, and Children's Screen Time Recommendations

In this episode, Dr. Chi-Ming Chow introduces retatrutide, a new obesity treatment, discussing its mechanism, effects, and clinical results. He highlights the importance of consulting healthcare professionals and the risks of unregulated weight loss drugs. The episode shifts to Ebola testing in Ontario, covering infection control measures and the WHO's declaration on the Ebola outbreak, including symptoms, spread, and historical context. Dr. Chow addresses the issue of rising screen time among children, discussing associated risks and impacts while providing recommendations and Canadian guidelines for healthy screen time. The episode concludes with Dr. Chow's final thoughts and a wrap-up.